CLINICAL_TRIALS
trial_result
· 2011-06-03
Clinical Trial Update: Phase IIIB Subcutaneous Missed Dose Study [Phase 3]
Summary
Phase IIIB subcutaneous missed-dose study in rheumatoid arthritis has completed, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-06-03